PRESCRIPTION DRUG ETHICAL ACT House SponsorsRep. Jack D. Franks 1/13/2009HouseSession Sine Die New Act30 ILCS 105/5.675 new Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director of Public Health the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in the State authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose. Provides that the civil penalties collected under the Act shall be deposited into the Prescription Drug Ethical Marketing Fund, which is created as a special fund in the State treasury, to be used for enforcement of the Act. Amends the State Finance Act to reflect the creation of the Prescription Drug Ethical Marketing Fund. 2/7/2007HouseFiled with the Clerk by Rep. Jack D. Franks 2/7/2007HouseFirst Reading 2/7/2007HouseReferred to Rules Committee 2/15/2007HouseAssigned to Consumer Protection Committee 3/23/2007HouseRule 19(a) / Re-referred to Rules Committee 1/13/2009HouseSession Sine Die